BioCryst Pharmaceuticals, Inc. is an innovative biotechnology firm based in Durham, North Carolina, specializing in the discovery and development of novel oral and small molecule therapeutics for rare diseases and conditions. With a strong focus on enhancing patient outcomes, BioCryst’s proprietary pipeline includes promising treatments targeting unmet medical needs, particularly in the areas of hereditary angioedema and viral infections. The company is distinguished by its commitment to scientific excellence and agility in drug development, positioning it as a significant player in the biotechnology sector for institutional investors seeking growth opportunities in rare disease therapeutics.
Click "Analyze" to generate stock analysis
BCRX Price Trend and Signals
BCRX Option Volumes & Open Interests (aggregated)
BCRX Put Call Ratios and IV (aggregated)
BCRX Financials
2025-10-21Bullishmacd_signal
Golden cross below zero detected.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.